Navigation Links
Mammograms Can Measure How Breast Cancer Drug Is Working: Study
Date:4/23/2013

MONDAY, April 22 (HealthDay News) -- Mammograms can be used to see how well breast cancer patients are responding to treatment with the drug tamoxifen, a new study suggests.

Researchers at the Karolinska Institute in Sweden report that women who saw a 20 percent or more reduction in breast density during tamoxifen treatment had a 50 percent lower risk of dying from breast cancer over an average of 15 years, compared with women who had little or no change in breast tissue density during treatment.

The study uncovered a link between reductions in breast density while on tamoxifen and a lowered risk of death. However, it didn't find a cause-and-effect relationship.

Using mammograms to determine if a patient is responding to tamoxifen can be done at an early stage of treatment, the researchers added.

The Swedish team looked at nearly 1,000 postmenopausal women who had been treated for breast cancer. About half of them had been treated with tamoxifen, according to the study, which was published online April 22 in the Journal of Clinical Oncology.

Tamoxifen is a common hormone-therapy drug typically given over five years to prevent relapse in women who have completed their primary breast cancer treatment. However, there has been no way to assess which patients are most likely to respond to tamoxifen treatment.

These findings suggest a possible method for doing so, the researchers said.

"What's needed is accurate measurement of mammographic density, which isn't currently routine," Per Hall, a professor in the department of medical epidemiology and biostatistics, said in a Karolinska Institute news release. "Measuring changes in density can be a simple and cheap means of assessing the effect of the treatment. If a patient is not responding to tamoxifen, maybe they should be given a different drug."

More information

The U.S. National Cancer Institute has more about breast cancer treatment.

-- Robert Preidt

SOURCE: Karolinska Institute, news release, April 22, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
2. Here Are the Women Who Need Mammograms in Their 40s: Study
3. No family history not a good reason for women 40-49 to stop yearly screening mammograms
4. Mammograms Beat Thermography for Breast Cancer Detection: Study
5. US mammograms decline after task force recommendation, Mayo Clinic finds
6. Mammograms Have Limited or No Effect on Breast Cancer Deaths: Study
7. Breast Cancer Charity Overstates Value of Mammograms: Researchers
8. Mammograms Do Not Prevent Advanced Breast Cancer, Study Suggests
9. For Older Women, Mammograms Every 2 Years Found as Good as Annual Test
10. Mammograms Every Other Year OK for Women Over 50: Study
11. False-Positive Mammograms Can Trigger Long-Term Distress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mammograms Can Measure How Breast Cancer Drug Is Working: Study
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology: